Patient presents for implantable cardioverter-defibrillator (ICD) management.  The patient's primary diagnosis is [Specific underlying heart condition, e.g., heart failure, ischemic cardiomyopathy, nonischemic cardiomyopathy, ventricular arrhythmia,  sudden cardiac arrest, Brugada syndrome, Long QT syndrome,  hypertrophic cardiomyopathy].  Current indications for ICD therapy include [Specific indication, e.g., primary prevention of sudden cardiac death, secondary prevention of sudden cardiac death,  symptomatic ventricular tachycardia, ventricular fibrillation].  Device interrogation reveals [Specific device findings, e.g., stable lead impedances, appropriate sensing and pacing thresholds, battery life of [duration], no evidence of inappropriate shocks or lead malfunction].  Patient reports [Patient-reported symptoms related to device or underlying condition, e.g., no palpitations, no syncope, no shocks delivered, no chest pain]. Physical examination reveals [Relevant physical findings, e.g., stable vital signs, regular heart rhythm, normal heart sounds, no edema]. Medications include [List of current medications including antiarrhythmics, beta-blockers, ACE inhibitors, etc.].  Plan of care includes continuation of current medications, optimization of heart failure therapy if applicable, patient education regarding device function and potential complications, and scheduled ICD follow-up in [ timeframe, e.g., 3 months, 6 months].  ICD coding includes [Relevant ICD-10 codes, e.g., Z45.01, Z45.02, I49.5,  plus code(s) for underlying cardiac condition].  Medical billing will reflect device interrogation and management.  This documentation supports medical necessity for ICD therapy and ongoing monitoring.